EnZeta Immunotherapies, Inc.

CIK 1994145 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for EnZeta Immunotherapies, Inc..

Recent SEC filings

FiledFormAccession number
Mar 6, 2026D/A0001994145-26-000001
Feb 20, 2025D0001994145-25-000001
Sep 29, 2023D0001994145-23-000003
Sep 26, 2023D0001994145-23-000002